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Abstract
Background: Treatment planning especially liver resection in cholangiocarcinoma (CCA) depends on the extension
of tumor and lymph node metastasis which is included as a key criterion for operability. Magnetic resonance
imaging (MRI) offers a rapid and powerful tool for the detection of lymph node metastasis (LNM) and in the current
manuscript is assessed as a critical tool in the preoperative protocol for liver resection for treatment of CCA.
However, the accuracy of MRI to detect LNM from CCA had yet to be comprehensively evaluated.
Methods: The accuracy of MRI to detect LNM was assessed in a cohort of individuals with CCA from the
Cholangiocarcinoma Screening and Care Program (CASCAP), a screening program designed to reduce CCA in
Northeastern Thailand by community-based ultrasound (US) for CCA. CCA-positive individuals are referred to one of
the nine tertiary centers in the study to undergo a preoperative protocol that included enhanced imaging by MRI.
Additionally, these individuals also underwent lymph node biopsies for histological confirmation of LNM (the “gold
standard”) to determine the accuracy of the MRI results.
Results: MRI accurately detected the presence or absence of LNM in only 29 out of the 51 CCA cases (56.9%, 95%
CI 42.2–70.7), resulting in a sensitivity of 57.1% (95% CI 34.0–78.2) and specificity of 56.7% (95% CI 37.4–74.5), with
positive and negative predictive values of 48.0% (95% CI 27.8–68.7) and 65.4% (95% CI 44.3–82.8), respectively. The
positive likelihood ratio was 1.32 (95% CI 0.76–2.29), and the negative likelihood ratio was 0.76 (95% CI 0.42–1.36).
Conclusions: MRI showed limited sensitivity and a poor positive predictive value for the diagnosis of LNM for CCA,
which is of particular concern in this resource-limited setting, where simpler detection methods could be utilized
that are more cost-effective in this region of Thailand. Therefore, the inclusion of MRI, a costly imaging method,
should be reconsidered as part of protocol for treatment planning of CCA, given the number of false positives,
especially as it is critical in determining the operability for CCA subjects.
Keywords: Cholangiocarcinoma, Magnetic resonance imaging, Lymph node metastasis, Accuracy, Preoperative
protocol
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Background
Cholangiocarcinoma (CCA) is a primary hepatic malignancy that arises along the intrahepatic and extrahepatic
bile ducts. It is the second most common liver cancer
globally [1] and the most common liver cancer in the
resource-limited setting of the northeastern provinces of
Thailand [2], where its high incidence is due to risk factors
unique to this tropical disease, i.e., the consumption of
raw or undercooked cyprinoid fish, which are the intermediate hosts for the food-borne trematode Opisthorchis
viverrini (Ov), one of the few carcinogenic pathogens [3].
When detected early, CCA is amenable to liver resection,
which substantially improves survival [4, 5], with the median survival time of liver resection patients at 23 months
compared with less than 8 months in inoperable patients
[5]. However, due to the asymptomatic or non-specific nature of the symptoms associated with CCA during its early
stages, this cancer is often detected at an advanced stage,
with a concomitantly poor prognosis and dismal survival
rate [5]. The Cholangiocarcinoma Screening and Care
Program (CASCAP) was instituted in Northeast Thailand
with the objective of conducting community-based ultrasound (US) screening programs for the early diagnosis of
CCA, making liver resection a viable post-diagnostic
option for the treatment of CCA [6].
As the objective of CASCAP is to increase survival
from CCA by aggressively screening for this cancer by
mobile US units in Ov-endemic areas, a critical component of this endeavor was to establish a preoperative
evaluation protocol for liver resection for CCA, which
would include factors such as (1) tumor infiltration
beyond the second order bile duct branches, (2) tumor
invasion of major vessels such as main hepatic artery
or portal vein, and (3) the extent of lymph node metastasis (LNM) [7–15]. Due to its location in the hepatoduodenal ligament, CCA quickly metastasizes outside
the liver via the lymph node system or perineural invasion [16, 17], even during the early stages of this bile
duct cancer. While several methods are available for
detecting LNM, CASCAP attempted magnetic resonance imaging (MRI) to scan for LNM as part of a preoperative evaluation protocol for CCA due to its speed
and “accuracy” in other cancer contexts [18]. However,
the accuracy of MRI for depicting LNM for CCA has
to be studied for each individual cancer, and it has
been poorly studied of CCA [19–21]. The assessment
of LNM by MRI for CCA is seldom performed due to
limited access to tertiary care centers in this resourcepoor setting. Herein, we investigated the diagnostic
performance of MRI for the detection of LNM, as a
part of the preoperative evaluation protocol for CCA,
compared to the “gold standard” of pathological confirmation of individuals suspected of CCA by lymph
node resection.
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Methods
Study setting: community-based risk stratification and
ultrasonography

This study was based on data from CASCAP, which is a
combined community and hospital-based cohort study
conducted in Ov-endemic areas in Northeastern Thailand
(www.cascap.in.th) and nine tertiary care hospitals in this
same region. The CASCAP study is comprised of two
cohorts. The first cohort is the “screening cohort,” which
includes individuals who were risk stratified using criteria
consisting of (1) their residence in Northeastern Thailand,
(2) age of 40 years or older (inclusive), (3) previous reported infection with the carcinogenic liver fluke Ov, (4)
previously reported treatment for Ov infection with praziquantel, and (5) self-reported consumption of raw or
undercooked freshwater fish, the second intermediate host
of Ov. Individuals considered at risk for Ov-induced CCA
underwent liver US as detailed in Khuntikeo et al. [6]. The
second cohort is a conventional cancer registry, where
patients were suspected of CCA during a routine US from
one of the nine participating hospitals.
Magnetic resonance cholangiopancreatography

Individuals included in the present study included those
enrolled in CASCAP who were suspected of CCA by US
or clinical symptoms and had a confirmatory magnetic resonance cholangiopancreatography (MRCP) or computerized tomography (CT) scanning at one of nine tertiary care
centers. The MRI used a 1.5–3.0 T system. Two different
MRCP techniques were applied: a single-shot rapid acquisition with relaxation enhancement (RARE) and a multislice half-Fourier acquisition single-shot turbo spin echo
(HASTE). The slabs of the single-shot RARE sequence
were obtained on various planes (e.g., coronal, axial, and
oblique) to allow for the optimal visualization of the bile
ducts. The number of thick-slab acquisitions ranged from
seven to nine per patient. Next, multislice HASTE images
were obtained in the coronal and oblique planes. Each
examination was performed during a single breath-hold.
The imaging parameters for the single-shot RARE
sequence were as follows: repetition time of ∞, effective
echo time of 1200 ms, echo train length of 240, flip angle
of 150°, slab thickness of 70 to 90 mm, field of view of 300
to 340 mm, matrix of 240 × 256, and an acquisition time
of 2.32 s. The imaging parameters for the multislice
HASTE sequence were as follows: repetition time of ∞,
effective echo time of 95 ms, echo train length of 128; flip
angle of 150°, section thickness of 4 mm without a gap
and 13 to 15 slices (range of coverage 52–60 mm), field of
view of 300 to 340 mm, matrix of 240 × 256, and an
acquisition time of 18 to 20 s. Fat saturation was used to
reduce a strong fat signal during image acquisition. The
total acquisition time for all of the imaging steps in the
MR imaging were less than 15 min.
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LNM determination

The determination of LNM by MRI was made by a
consensus between two board-certified radiologists using
the following morphological criteria: nodal size greater
than 10 mm in short axis diameter, central necrosis, and
inhomogeneous enhancement following intravenous
contrast medium injection [22–24]. In equivocal cases, a
gastrointestinal radiologist was also consulted. The
determination for surgery was attained by a consensus
between the surgeon and the patient, after the counseling
process was completed.
Gold standard pathological evaluation of LNM

In the case when a surgical treatment occurred, the operation types and plans were discussed with the doctors before the procedure. The time interval between MRI scan
and operation was about 1 month. Lymph node dissections
were performed in case of the presence of an enlarged or
abnormal consistency of the lymph nodes. These dissected
lymph nodes were sent for pathological examination. The
diagnosis of pathological LNM was done by two boardcertified pathologists. The procedures included each pathologist performing a gross and microscopic examination of
the tissue specimen separately with the pathological diagnosis and lymph node metastasis made by consensus. In
case of differences in the diagnosis between the two pathologists, immunohistochemistry strains were used to determine a consensus between both pathologists.
Data analysis

The descriptive statistics of patients and the type of tumor
were presented as mean and standard deviations, such as
age. Categorical variables were presented as numbers and
percentages. A comparison between LNM diagnosis using
an MRI scan and pathological diagnosis included the following parameters: sensitivity, specificity, positive predictive
values (PPV), negative predictive values (NPV), false positive rates, and false negative rates. They were calculated
along with their 95% confidence intervals (95% CI). These
diagnostic parameters were presented as either the overall
CCA or CCA stratified into intrahepatic, perihilar, and distal type based on the American Joint Committee on Cancer
(AJCC) criteria. All statistical analyses were conducted
using Stata13 (Stata Corp, College Station, TX, USA). Attached data sets 1-3 were used for all analysis (Additional
files 1, 2 and 3).
Ethical approval

This study was conducted according to the principles of
Good Clinical Practice (Chapter 2 of the International
Conference of Harmonized Tripartite Guideline for Good
Clinical Practice), the Declaration of Helsinki, and the national laws and regulations about clinical studies. CASCAP
was approved by Khon Kaen University Ethics Committee
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(HE551404) for Human Research and received written
informed consent from all patient participants.

Results
A total of 433 individuals suspected of CCA by US were
sent for MRI scanning, with a follow-up confirmation of
255 cases of CCA (58.9%). There were 133 (52.2%) individuals with intrahepatic CCA, 112 (43.9%) with perihilar
CCA, and 10 (3.92%) with distal CCA. In the CCA group
confirmed by MRI scans, 248 (97.3%) subjects also had
radiographic lymph node findings, with 125 (50.4%) showing LNM. Of these 255 MRI-confirmed CCA subjects,
130 received surgical treatments with pathologically confirmed CCA. The 51 underwent lymph node dissection,
with only 21 (41.2%) having confirmed LNM based on the
conventional pathological diagnosis (Fig. 1).
Of the 51 individuals who underwent lymph node
dissections, the mean age was found to be 61.5 years
(SD 10.3), with 33 out of 51 (64.7%) being males. Of
these individuals, 35.3% had intrahepatic, 60.8% perihilar,
and 3.9% distal CCA (Table 1).
The MRI scan accurately detected the presence or absence of LNM in 29 out of 51 CCA cases (56.9%, 95% CI
42.2–70.7), resulting in a sensitivity of 57.1% (95% CI
34.0–78.2) and a specificity of 56.7% (95% CI 37.4–74.5),
with a PPV and a NPV of 48.0% (95% CI 27.8–68.7) and
65.4% (95% CI 44.3–82.8), respectively. The positive likelihood ratio was 1.32 (95% CI 0.76–2.29), and the negative likelihood ratio was 0.76 (95% CI 0.42–1.36)
(Tables 2 and 3).
For intrahepatic CCA, the MRI scan had a sensitivity of
50.0% (95% CI 15.7–84.3) and a specificity of 88.9% (95%
CI 51.8–99.7), with a PPV and a NPV of 80.0% (95% CI
28.4–99.5) and 66.7% (95% CI 34.9–90.1), respectively.
The positive likelihood ratio was 4.50 (95% CI 0.63–32.4),
and the negative likelihood ratio was 0.56 (95% CI 0.27–
1.17) (Table 3). In the case of perihilar CCA, the MRI scan
had a sensitivity of 61.5% (95% CI 31.6–86.1) and a specificity of 38.9% (95% CI 17.3–64.3), with a PPV and NPV
of 42.1% (95% CI 20.3–66.5) and 58.3% (95% CI 27.7–
84.8), respectively. The positive likelihood ratio was 1.01
(95% CI 0.57–1.77), and the negative likelihood ratio was
0.99 (95% CI 0.40–2.43) (Table 3).
Discussion
The age-adjusted incidence rates for CCA in Northeastern
Thailand are 89.2 and 35.5 per 100,000 for males and females, respectively, which are among the highest in the
world. The high incidence of this relatively rare cancer in
Northeast Thailand is due to the dietary habits of the inhabitants of the region, who consume raw or undercooked
cyprinoid fish, the intermediate host of the food-borne
pathogen Opisthorchis viverrini. CCA tends to present
late, often going undetected until an advanced stage, when
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Fig. 1 Flow of subjects in the Cholangiocarcinoma Screening and Care Program (CASCAP). Abbreviations: CCA cholangiocarcinoma, U/S
ultrasonography, CT computerized tomography, MRI magnetic resonance imaging

overall survival is less than 12 months [4, 25–29]. Currently, the most successful treatment for CCA is radical
liver resection at an early stage of the disease and in the
absence of LNM. With its location in the hepatoduodenal
ligament, CCA tumors tend to metastasize outside the
liver either via the lymph node system or via perineural
invasion [16, 17]. Health disparities in this region of
Thailand exacerbate this poor prognosis, as there are limited early cancer screenings and minimal post-diagnostic
treatment. CASCAP was instituted in Northeastern
Thailand to resolve these health disparities associated with
CCA by conducting community-based US screening to
detect early CCA.
The development of a preoperative protocol for CCA
is central to the strategy of CASCAP. Currently, the preoperative protocol for CCA includes an (1) extension of
Table 1 Characteristics of patients and type of tumors presented
as number and percentage unless specified otherwise
Subjects
Mean age ± SD

Percent

61.5 ± 10.3 years

Sex
Male

33

64.7

Female

18

35.3

Intrahepatic

18

35.3

Perihilar

31

60.8

Distal

2

3.9

Type of tumor

SD standard deviation

the cancer to the hepatic artery or portal vein and (2)
extension of lymph node metastasis (LNM) [7–15]. CCA
cases that underwent liver resection in the presence of
pathologically confirmed LNM were reported to have a
zero 5-year survival rate [30–33], whereas CCA cases
that underwent liver resection in the absence of LNM
were reported to have a 35–72% 5-year survival rate
[33–36]. However, the specific outcome of liver MRI on
the surgical management of CCA has yet to be systematically evaluated. While several studies have estimated the
diagnostic accuracy of MRI as part of the preoperative
evaluation of bile duct involvement and vascular involvement [19, 20, 37], our study is the first to have determined the accuracy of MRI in the preoperative
evaluation of LNM in CCA.
In the current study, MRIs were observed to have limited utility for preoperative evaluation for CCA compared
to the “gold standard” of pathological confirmation of
LNM. An especially concerning finding was the high false
Table 2 Comparing the result of magnetic resonance imaging
and pathological diagnosis (subjects)
Lymph node pathology
Magnetic resonance
imaging scan

Total

Metastasis

Non-metastasis

Nodal
metastasis

12

13

25

Non-nodal
metastasis

9

17

26

Total

21

30

51
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Table 3 Diagnostic performance of magnetic resonance imaging in diagnosis of lymph node metastasis in different types of
cholangiocarcinoma
Diagnostic

Predictive value

Likelihood ratio

CCA

Sensitivity (95% CI)

Specificity (95% CI)

Positive (95% CI)

Negative (95% CI)

Positive (95% CI)

Negative (95% CI)

Intrahepatic

50.0

88.9

80.0

66.7

4.50

0.56

(23.0–72.2)

(51.8–99.7)

(28.4–99.5)

(34.9–90.1)

(0.63–32.9)

(0.27–1.17)

Perihilar

Overall

61.5

38.9

42.1

58.3

1.01

0.99

(31.6–86.1)

(17.3–64.3)

(20.3–66.5)

(27.7–84.8)

(0.57–1.77)

(0.40–2.43)

57.1

56.7

48.0

65.4

1.32

0.76

(34.0–78.2)

(37.4–74.5)

(27.8–68.7)

(44.3–82.8)

(0.76–2.29)

(0.42–1.36)

CCA cholangiocarcinoma, CI confidence interval

positive rate of MRIs for CCA LNM, which would exclude
individuals otherwise eligible for surgery. We quantified
the sensitivity of MRI scans in determining LNM for CCA
at 57.1%, which was far lower than other preoperative
resectability criteria such as the bile duct and vascular
involvement [19, 20, 37]. A factor that may limit the
accuracy of MRI scans in the assessment of CCA LNM is
the reliance on nodal size in the axial short axis because of the inability to detect microscopic metastasis
in normal-size nodes and to distinguish benign enlargement from malignant lymph nodes [12]. Our findings
are similar to a recent study that found the survival rate
of CCA with preoperative lymph node enlargement
improved after hepatectomy [38]. We also agree with a
study that recommended routine lymphadenectomy in
all cases of hepatectomy [36]. An important limitation
of this study is that MRI scanning was carried out at
nine different tertiary care centers, using different machines, techniques, and radiologists. This indicates the
possibility of variation in the data collection. Second,
the lymph node pathology, which is the gold standard
of this study, was determined in only some surgical
subjects: not all MRI scans confirmed CCA diagnosis.
The site and number of lymph nodes from MRI and
pathological diagnosis also might be different. This
might have an effect on our results. Finally, the time
between an MRI scan and surgical operation might
have affected the progression of the disease, as it may
affect the period during which LNM may occur.
Liver resection has long been shown to increase survival from CCA, though it is highly dependent on LNM.
Herein, we utilized the unique early screening program
and a large sample size (CASCAP) in Northeastern
Thailand to determine the quality of data for MRI scanning to determine LNM in the preoperative evaluation
for CCA. We found that MRI scanning for LNM had
limited sensitivity, with a low positive predictive value,
and a high number of false positives, which would define
eligible patients as inoperable. The evaluation of the
nodal metastasis based on this radiological imaging modality has significant clinical implications for the surgical

treatment of CCA. As such, we strongly recommend a
“reconsideration” of the inclusion of MRI results for
LNM in the preoperative evaluation for CCA, especially
when it is used as the single or principle criterion for
whether or not an individual will have curative liver
resection for CCA.

Conclusions
MRI has limited sensitivity and positive predictive value
for the diagnosis of LNM in CCA. Therefore, surgeons
should be aware of the number of false positives in
determining the inoperability of CCA subjects.
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